Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 16, Issue 6, Pages 866-875
Publisher
Informa UK Limited
Online
2015-05-28
DOI
10.1080/15384047.2015.1040958
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer stem cells, lymphangiogenesis, and lymphatic metastasis
- (2015) Shuang Li et al. CANCER LETTERS
- VEGF-VEGFR Signals in Health and Disease
- (2014) Masabumi Shibuya Biomolecules & Therapeutics
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HIF-1 Signaling in Drug Resistance to Chemotherapy
- (2014) N.A. Warfel et al. CURRENT MEDICINAL CHEMISTRY
- Cordycepin Down-Regulates Multiple Drug Resistant (MDR)/HIF-1α through Regulating AMPK/mTORC1 Signaling in GBC-SD Gallbladder Cancer Cells
- (2014) Wei-Ding Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
- (2014) Erik O. Pettersen et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Epidemiology of Breast Cancer
- (2014) Kristen A. Ban et al. Surgical Oncology Clinics of North America
- cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
- (2014) Joohyuk Sohn et al. Journal of Cancer
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer
- (2013) Faton Agani et al. CURRENT CANCER DRUG TARGETS
- Carbon ion radiotherapy of human lung cancer attenuates HIF-1 signaling and acts with considerably enhanced therapeutic efficiency
- (2013) Florentine S. B. Subtil et al. FASEB JOURNAL
- HiF-1α siRNA and Cisplatin in Combination SuppressTumor Growth in a Nude Mice Model of Esophageal Squamous Cell Carcinoma
- (2012) Hong-Ying Liao et al. Asian Pacific Journal of Cancer Prevention
- Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
- (2012) T. W. H. Meijer et al. CLINICAL CANCER RESEARCH
- The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
- (2011) S K Martin et al. LEUKEMIA
- HIF-1 as a Target for Cancer Chemotherapy, Chemosensitization and Chemoprevention
- (2011) Elena Monti et al. Current Molecular Pharmacology
- Characteristics of triple-negative breast cancer
- (2010) Tim C. de Ruijter et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases
- (2010) M. de Boer et al. JNCI-Journal of the National Cancer Institute
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transport proteins of the ABC family and multidrug resistance of tumor cells
- (2008) A. A. Stavrovskaya et al. BIOCHEMISTRY-MOSCOW
- Age-dependent impairment of HIF-1α expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells
- (2008) Lixin Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effect of Hypoxia-inducible Factor-1α Silencing on the Sensitivity of Human Brain Glioma Cells to Doxorubicin and Etoposide
- (2008) Lei Chen et al. NEUROCHEMICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now